R. Michael Kleine
President & Chief Executive Officer
Mike Kleine has been with Miramar Labs since January 2014. Mr. Kleine is an established leader with a proven track record of success in leading several global biomedical companies. With nearly two decades of experience in C-suite positions he has experience commercializing new technologies, increasing revenues, and growing organizations. Previous positions held include President and CEO roles with EndoGastric Solutions, Biosensors International Group, LTD, a publicly traded company, and MicroVention, a start-up which was acquired by Terumo.
Brigid A. Makes
Sr. Vice President and Chief Financial Officer
Brigid Makes has been with Miramar Labs since September 2011. Ms. Makes is a successful financial executive with over 30 years of experience in leading and building strong organizations, and delivering results. Her experience with IPOs and M&A in high growth and technology focused businesses, including large and small companies, was evident in her successful transition of AGA Medical through its IPO process and acquisition by St Jude Medical. Ms. Makes has also served in executive roles in finance, operations and R&D at Nektar Therapeutics, and in senior financial roles in Haemonetics, Lotus Development and GE.
Steven W. Kim
Chief Technology Officer
Steve Kim is an entrepreneur who co-founded Miramar Labs in 2007. Mr. Kim is passionate about medical technology innovation with over 100 issued patents and 23 years of experience in start-up medical device ventures. He has held various executive management positions in R&D, operations, and general management. Mr. Kim has experience working in various medical specialties including dermatology, oncology, cardiology, interventional radiology, and surgery. The product categories that he has developed include thermal ablation devices, capital equipment, disposables, implants, catheters, and surgical tools. Other start-up ventures include AneuRx (acquired by Medtronic), TransVascular (acquired by Medtronic), and Vivant Medical (acquired by Tyco Healthcare).
Vice President, Marketing
Rob Ellis has been with Miramar Labs since July 2014. Mr. Ellis brings over 20 years of experience in healthcare sales and marketing, with a focus in the last 12 years of building and leading global marketing teams with aesthetic device companies including Solta, Sciton, and Lumenis. His leadership has driven many successful global product launches in dermatology and plastic surgery. Mr. Ellis’ programs have captured the attention of physicians and patients through national exposure on The Today Show, Entertainment Tonight, The Doctors, People and Glamour magazine and he has been recognized with the Silver SABRE award for Public Relations. Mr. Ellis holds a BS in Biochemistry/Biophysics and an MBA.
Vice President, R&D
Dan Francis has been with Miramar Labs since November 2007. Mr. Francis is a Research and Development specialist with over 15 years of industry experience, including 12 years developing therapeutic energy delivery devices. With a history of new product innovation at LuMend and Cierra Inc. and expertise in design, materials and manufacturing processes, Mr. Francis contributes a strong technical background to the Miramar team.
Steven M. Higa
Vice President, Manufacturing
Steve Higa has been with Miramar Labs since April 2012. Mr. Higa is a proven leader with over seventeen years of experience leading operations, manufacturing, and product development teams in the medical device industry. With a reputation of fostering a culture of continuous improvement, Mr. Higa has successfully managed operations growth to support company revenue and sales goals. Prior companies include ZOLL Medical, Amira Medical (acquired by Roche), and Johnson & Johnson.
Senior Director Sales – US & Canada
Robert Tyson has been with Miramar Labs since September 2014. Mr. Tyson is a proven sales leader with over 20 years of medical device experience including a strong early foundation of more than ten years with Ethicon-Endo Surgery and Edwards Heart Valve Therapy. Since 2003 Mr. Tyson participated in launching several breakthrough aesthetic technologies while holding various sales leadership positions of increasing responsibility with Zeltiq, Ulthera, Reliant Technologies and Thermage. He joined Miramar in the fall of 2014 and helped orchestrate the formation of the Practice Development Team to improve practice support and integrate the new Optimized Treatment Protocol for miraDry customers.
Managing Director, Asia Pacific
James Lam has been with Miramar Labs since September 2012. Mr. Lam is a successful leader in the medical device industry with over 33 years of sales, marketing and general management experience in Asia Pacific, extensively in China. Mr. Lam possesses a proven track record managing sales and marketing operations that exceed $120 million and a reputation for driving sales excellence. Prior companies include Siemens AG, Stryker, Sherwood DG, Boston Scientific, AGA Medical and St. Jude Medical.